Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

BUY
$98.98 - $115.74 $9.89 Million - $11.6 Million
99,908 Added 449.57%
122,131 $14.1 Million
Q2 2023

Aug 11, 2023

BUY
$96.34 - $112.38 $691,432 - $806,551
7,177 Added 47.7%
22,223 $2.29 Million
Q1 2023

May 02, 2023

SELL
$107.32 - $113.5 $3.79 Million - $4.01 Million
-35,294 Reduced 70.11%
15,046 $1.64 Million
Q4 2022

Feb 02, 2023

BUY
$62.39 - $113.8 $3.08 Million - $5.62 Million
49,400 Added 5255.32%
50,340 $5.73 Million
Q3 2022

Nov 07, 2022

SELL
$58.92 - $84.67 $1.28 Million - $1.84 Million
-21,772 Reduced 95.86%
940 $60,000
Q2 2022

Aug 03, 2022

BUY
$79.4 - $116.36 $15,880 - $23,272
200 Added 0.89%
22,712 $1.81 Million
Q1 2022

Apr 29, 2022

SELL
$86.42 - $109.81 $452,495 - $574,965
-5,236 Reduced 18.87%
22,512 $2.37 Million
Q4 2021

Feb 03, 2022

SELL
$98.56 - $119.91 $784,636 - $954,603
-7,961 Reduced 22.29%
27,748 $2.59 Million
Q3 2021

Oct 18, 2021

SELL
$91.91 - $110.37 $592,084 - $711,003
-6,442 Reduced 15.28%
35,709 $3.91 Million
Q1 2021

Apr 26, 2021

BUY
$71.83 - $95.48 $2.02 Million - $2.68 Million
28,100 Added 199.99%
42,151 $3.88 Million
Q4 2020

Jan 25, 2021

BUY
$67.0 - $84.39 $348,199 - $438,574
5,197 Added 58.7%
14,051 $1.03 Million
Q3 2020

Oct 20, 2020

SELL
$55.23 - $79.93 $1.44 Million - $2.09 Million
-26,139 Reduced 74.7%
8,854 $688,000
Q2 2020

Jul 27, 2020

BUY
$30.2 - $56.98 $420,776 - $793,902
13,933 Added 66.16%
34,993 $1.95 Million
Q4 2019

Jan 17, 2020

BUY
$25.43 - $36.67 $7,629 - $11,001
300 Added 1.45%
21,060 $762,000
Q3 2019

Oct 17, 2019

SELL
$23.0 - $27.97 $316,802 - $385,258
-13,774 Reduced 39.89%
20,760 $565,000
Q2 2019

Jul 12, 2019

BUY
$22.81 - $28.48 $787,720 - $983,528
34,534 New
34,534 $831,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.